Financial News
Press Releases about Biondvax Pharma ADR
BiondVax Presenting at BIO CEO & Investor Conference
February 02, 2023
Via GlobeNewswire
Exposures
COVID-19
America Faces Shortage of Infectious Disease Experts
January 09, 2023
BiondVax to Present at Biotech Showcase 2023
January 05, 2023
Via GlobeNewswire
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Letter to Shareholders
January 03, 2023
Exposures
COVID-19
BiondVax CEO Issues Letter to Shareholders
December 30, 2022
Via GlobeNewswire
BiondVax Announces Closing of $8 Million Underwritten Public Offering
December 20, 2022
Via GlobeNewswire
BiondVax Announces Pricing of $8 Million Underwritten Public Offering
December 16, 2022
Via GlobeNewswire
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in ‘Stock2Me’ Podcast
December 13, 2022
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.